Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Cancer Res. 2010 Nov 16;71(1):216–224. doi: 10.1158/0008-5472.CAN-10-1725

Figure 3.

Figure 3

Pharmacokinetic studies of SMART-F, and -OH in mice and rats. (A) Concentration-time curve of SMARTs in ICR mice (n = 3); bars, SD. SMARTs were administrated 15mg/kg i.v. by tail vein injection. (B) Concentration-time curve of SMART-F in SD rats (n = 4); bars, SD. SD rats were dosed 2.5 mg/kg i.v. with the formulation DMSO/PEG300 (1/4). The pharmacokinetic data for SMART-H are shown for comparison, and were previously presented in Li et al. (Drug Metabolism and Disposition 2010).